Xconomy | Boston - Business + Technology in the Exponential Economy

Biotech, deals, Stem Cells

PerkinElmer-ViaCell Deal Done

Rebecca Zacks 11/15/07

Waltham, MA-based PerkinElmer (NYSE: PKI) announced today that it has completed its acquisition of Cambridge’s ViaCell (NASDAQ: VIAC). The $300 million deal was first announced early in October. Shares of PerkinElmer were essentially flat at midday, at $27.05.


Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.